CAR T cell therapy could reach beyond cancer pennmedicine NatureMedicine CellCellPress
Engineered immune cells, known as CAR T cells, have shown the world what personalized immunotherapies can do to fight blood cancers. Now, investigators have reported highly promising early results for CAR T therapy in a small set of patients with the autoimmune disease lupus.
There are now six FDA-approved CAR T cell therapies in the United States, for six different cancers. The therapies have revolutionized the treatment of certain B cell leukemias, lymphomas, and otherFrom the start of CAR T research, experts believed that T cells could be engineered to fight many conditions other than B cell cancers.
In the German study, the patients—five young adults—did not benefit from standard lupus treatments. Yet, all went into remission, and were able to stop taking their lupus drugs within three months of a single, relatively small dose of CAR T therapy, which essentially removed their existing B cells.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Driver stuck in Leeds car park forced to abandon car in traffic chaosDriver stuck in Leeds car park forced to send family home before abandoning car in traffic chaos
Weiterlesen »
Providing a bright future with cell therapiesCell therapies have been getting a great deal of attention as of late—most notably, gene-modified cell therapies for cancer immunology, such as CAR T therapies.
Weiterlesen »
Single-cell profiling of vascular endothelial cells reveals progressive organ-specific vulnerabilities during obesity - Nature MetabolismBondareva and Rodríguez-Aguilera et al. use scRNA-seq to analyze transcriptomes of 375,000 endothelial cells from seven organs in male mice at various stages of obesity to identify organ-specific vulnerabilities.
Weiterlesen »
Intestinal microorganisms influence white blood cell levels, study findsIntestinal bacteria composition is crucial to driving the recovery of neutrophil counts in the blood of mice following treatments such as stem cell transplants or chemotherapy.
Weiterlesen »
JCI - A FOXO1-dependent transcription network is a targetable vulnerability of mantle cell lymphomas
Weiterlesen »
The possibilities of stem cell therapiesThis article explores the possibilities of stem cell therapies.
Weiterlesen »